Diagnose Francisella tularensis as agent of infection
False-positives or negatives may occur due to vaccinations, anamnestic responses, antibiotic therapy, autoagglutinins and a variety of other disease states
Order only if at least 7 days post disease onset. Seroconversion indicated by a fourfold increase in titers during illness is considered diagnostic
Cross-reactions may occur between Brucella, Yersinia or Rickettsia and F. tularensis antigens and antisera; parallel tests should be run with those antigens
Additional Tests Available
Click on number for test-specific information in the ARUP Laboratory Test Directory
Test Name and Number
Comments
Organism Identification by 16S rDNA Sequencing 0060720
Method: Standard reference procedures for aerobic bacterial identification and/or 16s rDNA sequencing for select bacterial isolates.
Aerobic Organism Identification with Reflex to Susceptibility 0065070
Method: Standard reference procedures for aerobic bacterial identification and/or 16s rDNA sequencing for select bacterial isolates and susceptibility tests.
General References
Choi E.Tularemia and Q fever.Med Clin North Am. 2002;86(2):393-416. (Link to PubMed)
Conlan JW.Vaccines against Francisella tularensis--past, present and future.Expert Rev Vaccines. 2004;3(3):307-314. (Link to PubMed)
Cunha BA.The atypical pneumonias: clinical diagnosis and importance.Clin Microbiol Infect. 2006;12 Suppl 3:12-24. (Link to PubMed)
Eliasson H, Broman T, Forsman M, Back E.Tularemia: current epidemiology and disease management.Infect Dis Clin North Am. 2006;20(2):289-311, ix. (Link to PubMed)
Ellis J, Oyston PC, Green M, Titball RW.Tularemia.Clin Microbiol Rev. 2002;15(4):631-646. (Link to PubMed)
Keim P, Johansson A, Wagner DM.Molecular epidemiology, evolution, and ecology of Francisella.Ann N Y Acad Sci. 2007;1105:30-66. (Link to PubMed)
Sjostedt A.Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations.Ann N Y Acad Sci. 2007;1105:1-29. (Link to PubMed)
Tarnvik A, Berglund L.Tularaemia.Eur Respir J. 2003;21(2):361-373. (Link to PubMed)
Tarnvik A, Chu MC.New approaches to diagnosis and therapy of tularemia.Ann N Y Acad Sci. 2007;1105:378-404. (Link to PubMed)
Wortmann G.Pulmonary manifestations of other agents: brucella, Q fever, tularemia and smallpox.Respir Care Clin N Am. 2004;10(1):99-109. (Link to PubMed)
Reviewed by
Carney, Heather, M.D. Assistant Medical Director, Transfusion Services at ARUP Laboratories; Pathology, University of Utah
Litwin, Christine, M.D. Medical Director, Immunology at ARUP Laboratories; Professor, Clinical Pathology, University of Utah
Petti, Cathy A., M.D. Medical Director, Infectious Diseases at ARUP Laboratories; Assistant Professor, Pathology and Medicine, University of Utah
Comprehensive Review: March 2008
Last Update: July 2008